Cuba vs Europe & Central Asia (IDA & IBRD countries): Immunization, Hib3
Immunization, Hib3 over time
- Cuba
- Europe & Central Asia (IDA & IBRD countries)
How they compare
Cuba currently reports 99.0% against 93.4% in Europe & Central Asia (IDA & IBRD countries), a difference of 5.6%.
That makes Cuba's figure about 1.1 times Europe & Central Asia (IDA & IBRD countries)'s.
Across all 26 years both countries report, Cuba has been ahead every year.
Cuba ranks 1st and Europe & Central Asia (IDA & IBRD countries) ranks 3rd of 191 countries.
Cuba has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Cuba | Europe & Central Asia (IDA & IBRD countries) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 99.0% | 0.0% | 99.0% | Cuba |
| 2000s | 97.6% | 13.2% | 84.4% | Cuba |
| 2010s | 97.6% | 64.0% | 33.6% | Cuba |
| 2020s | 99.0% | 83.7% | 15.3% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Cuba or Europe & Central Asia (IDA & IBRD countries)?
- Cuba, at 99.0% against 93.4% in Europe & Central Asia (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hib3 between Cuba and Europe & Central Asia (IDA & IBRD countries)?
- 5.6%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Europe & Central Asia (IDA & IBRD countries)?
- 26 years are reported by both, from 1999 to 2024.
- How do Cuba and Europe & Central Asia (IDA & IBRD countries) rank globally for immunization, hib3?
- Cuba ranks 1st and Europe & Central Asia (IDA & IBRD countries) ranks 3rd of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.